Latest news with #BlueNordASA
Yahoo
14-05-2025
- Business
- Yahoo
BlueNord Announces First Quarter 2025 Results: Tyra Production Ramp-Up Continues and Second Distribution to Shareholders Proposed
OSLO, Norway, May 14, 2025 /PRNewswire/ -- BlueNord ASA ("BlueNord" or the "Company") today published its first quarter 2025 results, highlighting robust base production, continued progress at the Tyra hub and a strong liquidity position of USD 684 million. In addition, BlueNord is proposing its second shareholder distribution of USD 38 million for Q1 2025. This is expected to be declared and paid alongside the USD 215 million proposed distribution for 2024 once the RBL Completion Test for Tyra is met. Highlights: Net hydrocarbon production of 29.8 mboe/d in Q1 Revenues of USD 171 million for the quarter and EBITDA of USD 80 million Pre-Tax Operating Cash Flow of USD 70 million for the quarter Post-Tax Operating Cash Flow of USD 55 million for the quarter Strong liquidity position at quarter end of USD 684 million and cash on balance sheet of USD 414 million following release of cash in escrow Attractive hedges added during the quarter at favourable prices for 2025 and 2026, further securing future cashflow from the Company's operational portfolio Proposed shareholder distribution of USD 38 million for Q1 2025 Full technical capacity on Tyra during Q1 with final phase of ramp-up progressing Net 2P Reserves at 194 mmboe and a Reserves Replacement Ratio of 189% Operational The base assets, Dan, Gorm and Halfdan continued their stable and reliable production and delivered within guidance. Following the success of the HEMJ well which will extend plateau from Tyra significantly, the need for near-term infill wells to fill production capacity is reduced, and as such, the partners in the DUC have decided to optimise the drilling schedule of infill wells. This will reduce near-term cost and defer infill activities from 2025 to 2026/2027. TyraTyra ramp-up is progressing and has to date achieved a peak production of c.26 mboe/d net to BlueNord with plateau production of c.30 mboe/d expected in May 2025. Reservoir performance has been strong and, while 91% of the wells have now been commissioned, current production is being delivered by less than 50% of the total well stock. FinancialThe stable production from the base assets continued to contribute to the financial performance, while lower than expected volumes from Tyra, due to operational occurrences during the restart, resulted in penalties on gas sales. However, with Tyra in its final phase, restricted cash on escrow of USD 158 million was released during the quarter, resulting in a robust liquidity position of USD 684 million and cash on balance sheet of USD 414 million. In addition, the Company took advantage of the favourable commodity price sentiment during the quarter and added hedges on gas and oil for 2025 and 2026 at attractive prices. "BlueNord entered 2025 with strong operational momentum, having seen Tyra reach maximum technical capacity in the fourth quarter of 2024. While Dan, Halfdan, and Gorm have continued their track record of stable, predictable production in line with guidance, reaching plateau at Tyra has taken longer than expected. That said, we are now in a strong position with a positive outlook. In early May, Tyra production net to BlueNord peaked at over 26 mboe/d, with underlying reservoir performance continuing to exceed expectations. Together with the operator, our focus is on achieving stable operations and maximising operational efficiency at a hub that will support BlueNord's business through at least 2042. The transition of Tyra from development to delivery sets the stage for meaningful shareholder returns. For the first quarter of 2025, we are proposing a $38 million distribution, representing 70% of net operating cashflow. With a resilient portfolio of gas-weighted growth, low-cost structure, and strengthened liquidity, BlueNord is well positioned to deliver sustainable cashflow, even amidst commodity market volatility. Our focus remains clear: to maximise operational value, maintain capital discipline, and deliver on our core commitment to shareholder returns," said Euan Shirlaw, Chief Executive Officer of BlueNord. The report and investor presentation may be downloaded from the Company's website or The Company will host a webcast today at 10:00 CEST. To join webcast: Contact:Cathrine F. Torgersen, Chief Corporate Affairs OfficerPhone: +47 915 28 501Email: This information is considered to be inside information pursuant to the EU Market Abuse Regulation, and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. The stock exchange announcement was published by Cathrine Torgersen, Chief Corporate Affairs Officer, BlueNord ASA, at the date and time as set out above. This information was brought to you by Cision The following files are available for download: BlueNord Q1 2025 Report BlueNord Q1 2025 Presentation View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24-03-2025
- Business
- Yahoo
March 2025's European Stocks Possibly Priced Below Their Estimated Value
As the pan-European STOXX Europe 600 Index ended higher, breaking a streak of losses, investors are cautiously optimistic amid mixed signals from global economic policies and trade tensions. In this environment, identifying stocks that may be undervalued can offer potential opportunities for those looking to navigate the complexities of market fluctuations and economic uncertainties. Name Current Price Fair Value (Est) Discount (Est) Absolent Air Care Group (OM:ABSO) SEK260.00 SEK511.61 49.2% Romsdal Sparebank (OB:ROMSB) NOK130.30 NOK259.93 49.9% Vimi Fasteners (BIT:VIM) €0.97 €1.91 49.2% CTT Systems (OM:CTT) SEK221.00 SEK440.81 49.9% Comet Holding (SWX:COTN) CHF233.00 CHF464.46 49.8% Net Insight (OM:NETI B) SEK4.82 SEK9.58 49.7% Deutsche Beteiligungs (XTRA:DBAN) €26.55 €53.05 50% dormakaba Holding (SWX:DOKA) CHF681.00 CHF1356.93 49.8% Melhus Sparebank (OB:MELG) NOK167.04 NOK329.29 49.3% Neosperience (BIT:NSP) €0.532 €1.06 49.7% Click here to see the full list of 212 stocks from our Undervalued European Stocks Based On Cash Flows screener. Let's review some notable picks from our screened stocks. Overview: Altri SGPS is a company that produces and sells cellulosic fibers both in Portugal and internationally, with a market cap of €1.28 billion. Operations: The company's revenue primarily comes from the production and commercialization of cellulosic fibers, totaling €710.40 million. Estimated Discount To Fair Value: 43.1% Altri SGPS is trading at €6.23, significantly below its estimated fair value of €10.95, suggesting it may be undervalued based on cash flows. Recent earnings results show strong net income growth from €42.8 million to €107.2 million year-over-year, highlighting robust profitability despite revenue growing slower than 20% annually. However, interest payments are not well covered by earnings and the dividend track record is unstable, which could pose risks to potential investors seeking stability in returns. The analysis detailed in our Altri SGPS growth report hints at robust future financial performance. Click here to discover the nuances of Altri SGPS with our detailed financial health report. Overview: BlueNord ASA is an oil and gas company engaged in the exploration, development, and production of hydrocarbon resources across Norway, Denmark, the Netherlands, and the United Kingdom with a market cap of NOK17.60 billion. Operations: The company's revenue is primarily generated from its Oil & Gas - Exploration & Production segment, amounting to $702.30 million. Estimated Discount To Fair Value: 39.3% BlueNord ASA, trading at NOK664, is significantly below its estimated fair value of NOK1094.56, indicating it is undervalued based on cash flows. Despite a recent net loss of US$70.8 million for 2024 and interest payments not well covered by earnings, the company is forecast to achieve high profitability growth over the next three years. Recent operational challenges at Tyra II are expected to be resolved soon, potentially enhancing production efficiency and financial performance going forward. Our earnings growth report unveils the potential for significant increases in BlueNord's future results. Click to explore a detailed breakdown of our findings in BlueNord's balance sheet health report. Overview: Bonesupport Holding AB (publ) is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK21.85 billion. Operations: The company's revenue primarily comes from its Pharmaceuticals segment, generating SEK898.73 million. Estimated Discount To Fair Value: 42.8% Bonesupport Holding, trading at SEK331.8, is significantly undervalued with an estimated fair value of SEK580.34 based on cash flow analysis. Despite a decrease in net profit margin from 41.5% to 14.9% over the past year, its earnings and revenue are forecast to grow substantially faster than the Swedish market over the next three years. Recent positive study results for CERAMENT products may bolster future growth prospects and enhance profitability further. Upon reviewing our latest growth report, Bonesupport Holding's projected financial performance appears quite optimistic. Unlock comprehensive insights into our analysis of Bonesupport Holding stock in this financial health report. Click through to start exploring the rest of the 209 Undervalued European Stocks Based On Cash Flows now. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTLS:ALTR OB:BNOR and OM:BONEX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
21-02-2025
- Business
- Yahoo
February 2025's Stock Selections Possibly Priced Below Estimated Worth
In February 2025, global markets are experiencing a mix of optimism and caution, with U.S. stock indexes nearing record highs amid an environment of accelerating inflation and uncertain trade policies. As investors navigate these complex conditions, identifying undervalued stocks becomes crucial; such stocks may offer potential opportunities when their intrinsic value is not fully reflected in their current market price. Name Current Price Fair Value (Est) Discount (Est) Ningbo Sanxing Medical ElectricLtd (SHSE:601567) CN¥26.41 CN¥51.88 49.1% Vimi Fasteners (BIT:VIM) €0.97 €1.91 49.2% Hibino (TSE:2469) ¥2770.00 ¥5502.58 49.7% Shanghai Haohai Biological Technology (SEHK:6826) HK$26.30 HK$52.47 49.9% Power Wind Health Industry (TWSE:8462) NT$110.50 NT$220.43 49.9% América Móvil. de (BMV:AMX B) MX$15.07 MX$29.71 49.3% Accent Group (ASX:AX1) A$2.11 A$4.19 49.6% Saigon Thuong Tin Commercial Bank (HOSE:STB) ₫38750.00 ₫76325.14 49.2% Com2uS (KOSDAQ:A078340) ₩48250.00 ₩96043.58 49.8% Shenzhen Anche Technologies (SZSE:300572) CN¥18.75 CN¥36.88 49.2% Click here to see the full list of 906 stocks from our Undervalued Stocks Based On Cash Flows screener. Let's explore several standout options from the results in the screener. Overview: BlueNord ASA is an oil and gas company engaged in the exploration, development, and production of hydrocarbon resources across Norway, Denmark, the Netherlands, and the United Kingdom with a market cap of NOK18.26 billion. Operations: The company's revenue is primarily derived from its oil and gas exploration and production segment, totaling $702.30 million. Estimated Discount To Fair Value: 32.9% BlueNord ASA is currently trading at a significant discount, approximately 32.9% below its estimated fair value of NOK1026.61, indicating potential undervaluation based on discounted cash flows. Despite recent challenges leading to a net loss of US$70.8 million in 2024, the company forecasts robust annual revenue growth of 12.8%, outpacing the Norwegian market average and signaling future profitability within three years, although interest payments are not well covered by earnings presently. Our comprehensive growth report raises the possibility that BlueNord is poised for substantial financial growth. Get an in-depth perspective on BlueNord's balance sheet by reading our health report here. Overview: Bonesupport Holding AB (publ) is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK22.70 billion. Operations: The company generates revenue primarily from its Pharmaceuticals segment, amounting to SEK814.46 million. Estimated Discount To Fair Value: 17.4% Bonesupport Holding is trading at SEK345, below its estimated fair value of SEK417.72, suggesting undervaluation based on cash flows. The company anticipates revenue growth of 33.8% annually and earnings growth of 73.1%, both surpassing the Swedish market averages. Recent positive clinical study results for CERAMENT products could enhance future revenue streams, although current profit margins have decreased from last year's 41% to 11.1%. The growth report we've compiled suggests that Bonesupport Holding's future prospects could be on the up. Dive into the specifics of Bonesupport Holding here with our thorough financial health report. Overview: Lundin Gold Inc. is a Canadian mining company with a market cap of CA$9.05 billion, focusing on gold production and exploration activities. Operations: The company generates revenue primarily from its Fruta Del Norte mining operations, amounting to $1.04 billion. Estimated Discount To Fair Value: 34.3% Lundin Gold is trading at CA$38.37, significantly below its estimated fair value of CA$58.42, indicating potential undervaluation based on cash flows. The company reported 2024 sales of US$1.19 billion with net income rising to US$426.05 million from the previous year, supported by increased gold production and successful resource conversion at Fruta del Norte. Earnings are forecasted to grow substantially above market averages, while revenue growth is expected to outpace the Canadian market rate. Our growth report here indicates Lundin Gold may be poised for an improving outlook. Click here and access our complete balance sheet health report to understand the dynamics of Lundin Gold. Unlock more gems! Our Undervalued Stocks Based On Cash Flows screener has unearthed 903 more companies for you to here to unveil our expertly curated list of 906 Undervalued Stocks Based On Cash Flows. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OB:BNOR OM:BONEX and TSX:LUG. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
